South African daffodils may be a future cure for depression
Scientists at the University of Copenhagen have previously documented that substances from the South African plant species Crinum and Cyrtanthus – akin to snowdrops and daffodils – have an effect on the mechanisms in the brain that are involved in depression. This research has now yielded further results, since a team based at the Faculty of Health and Medical Sciences has recently shown how several South African daffodils contain plant compounds whose characteristics enable them to negotiate the defensive blood-brain barrier that is a key challenge in all new drug development. “Several of our plant compounds can probably be smuggled past the brain’s effective barrier proteins. We examined various compounds for their influence on the transporter proteins in the brain. This study was made in a genetically-modified cell model of the blood-brain barrier that contains high levels of the transporter P-glycoprotein. Our results are promising, and several of the chemical compounds studied should therefore be tested further, as candidates for long-term drug development,” says Associate Professor Birger Brodin.
“The biggest challenge in medical treatment of diseases of the brain is that the drug cannot pass through the blood-brain barrier. The blood vessels of the brain are impenetrable for most compounds, one reason being the very active transporter proteins. You could say that the proteins pump the drugs out of the cells just as quickly as they are pumped in. So it is of great interest to find compounds that manage to ‘trick’ this line of defence.” New cooperation between biologists and organic chemists It will nonetheless be a long time before any possible new drug reaches our pharmacy shelves: “This is the first stage of a lengthy process, so it will take some time before we can determine which of the plant compounds can be used in further drug development,” says Birger Brodin. Yet this does not curb his enthusiasm for the opportunities from the interdisciplinary cooperation with organic scientists from the Department of Drug Design and Pharmacology and the Natural History Museum of Denmark. “In my research group, we have had a long-term focus on the body’s barrier tissue – and in recent years particularly the transport of drug compounds across the blood-brain barrier. More than 90 per cent of all potential drugs fail the test by not making it through the barrier, or being pumped out as soon as they do get in. Studies of natural therapies are a valuable source of inspiration, giving us knowledge that can also be used in other contexts,” Birger Brodin emphasises.
Source: University of Copenhagen
André Huss Eriksson, Nina Rønsted, Semiha Güler, Anna Katharina Jäger, Júlia Rodríguez Sendra, Birger Brodin. In-vitro evaluation of the P-glycoprotein interactions of a series of potentially CNS-active Amaryllidaceae alkaloids. Journal of Pharmacy and Pharmacology, 2012; DOI: 10.1111/j.2042-7158.2012.01536.x
This web site is neither for advertising nor dispensing of medical advice. Clients who consult with Dr. Weeks receive information in an educational context in an effort to learn about optimizing care with their local health care practitioners. Dr. Weeks formerly practiced on Whidbey Island off the coast of Washington.
Share This Post
South African daffodils may be a future cure for depression Scientists at the University of Copenhagen have previously documented that substances from the South African plant species Crinum and Cyrtanthus – akin to snowdrops and daffodils – have an effect on the mechanisms in the brain that are involved in depression. This research has now…
The information contained on these web pages is derived from Dr. Weeks’ years of clinical experience and his review of scientific literature. However, these ideas and information are for your education and entertainment only. They are positively not intended to be a substitute for careful medical evaluation and treatment by a competent, licensed personal health care professional. Dr. Weeks and his associates do not recommend changing any current medications or adding any new therapies without personally consulting a fully qualified physician. Dr. Weeks and his staff specifically disclaim any liability arising directly or indirectly from information contained on these Web pages.
Varying and even conflicting views are held by other segments of the medical profession. The information presented on these Web pages is intended to be educational and entertaining in nature and is not intended as a basis for diagnosis or treatment. This information is current at the time of posting on the World Wide Web, and is published and distributed as a courtesy to the public.